Immunotherapy, which enhances the immune system's T cell response to eliminate cancer cells, has emerged as a key approach in ...

The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and ...

Immune checkpoint inhibitor tumor regression may indicate which patients with hepatocellular carcinoma experience improved ...

Researchers from the National Defense Medical Center in Taiwan have identified an increased risk of psoriasis in patients ...

Researchers conducted a nationwide cohort study using data from the Taiwan National Health Insurance database and the Taiwan ...

Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its ...

About one-third of U.S. patients with cancer can be treated immune checkpoint inhibitors, drugs that take the brakes off the ...

The most common immune-related adverse events were skin and endocrine events. As many as 40% of cancer patients receiving immune checkpoint inhibitors (ICIs) experience immune-related adverse events ...

Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk localized, muscle-invasive disease, according to a new editorial.

Chavez, MD, discusses the efficacy of immunotherapy for the potential treatment of extensive-stage small cell lung cancers.

A clinical trial at WashU Medicine shows promising results for a personalized vaccine designed to prevent recurrence in ...

Patients with cancer who receive immune checkpoint inhibitors (ICIs) have more than twice the risk for developing psoriasis compared with those who receive other treatments. Researchers conducted a ...